| 注册
首页|期刊导航|中国感染控制杂志|多重耐药菌医院感染直接经济负担的系统评价

多重耐药菌医院感染直接经济负担的系统评价

凌玲 吴伟旋 孙树梅 周浩 于芳 向前

中国感染控制杂志2017,Vol.16Issue(7):616-621,6.
中国感染控制杂志2017,Vol.16Issue(7):616-621,6.DOI:10.3969/j.issn.1671-9638.2017.07.006

多重耐药菌医院感染直接经济负担的系统评价

Systematic evaluation on direct economic burden of healthcare-associated infection due to multidrug-resistant organisms

凌玲 1吴伟旋 1孙树梅 1周浩 1于芳 1向前1

作者信息

  • 1. 南方医科大学南方医院,广东 广州 510515
  • 折叠

摘要

Abstract

Objective To understand the direct economic burden of healthcare-associated infection(HAI)due to multidrug-resistant organisms(MDROs).Methods Computer retrieval of CNKI,Wanfang,VIP,PubMed,Sci-enceDirect,and Cochrane databases on literatures about economic burden of MDRO HAI at home and abroad were performed,the retrieval time was from database establishment to December 2015,systematic evaluation of the liter-atures was obtained.Results According to the inclusion and exclusion criteria,as well as through Newcastle-Otta-wa Scale (NOS)for evaluating the literatures,19 literatures were included.In 12 studies about methicillin-resistant Staphylococcusaureus infection,the direct economic cost varied from $916.61 to $62908.00;in 4 studies about MDRO Acinetobacterbaumannii infection,the direct economic cost varied from$4644.00 to $98575.00.Direct economic cost due to extended-spectrumβ-lactamases-producing Enterobacteriaceae was $2824.14-$30093.00. Conclusion MDRO HAI will increase economic cost of both hospitals and patients,prevention and control measures should be taken .

关键词

医院感染/多重耐药菌/直接经济负担/系统评价

Key words

healthcare-associated infection/multidrug-resistant organism/direct economic burden/systematic evaluation

分类

医药卫生

引用本文复制引用

凌玲,吴伟旋,孙树梅,周浩,于芳,向前..多重耐药菌医院感染直接经济负担的系统评价[J].中国感染控制杂志,2017,16(7):616-621,6.

基金项目

广东省医学科学技术研究基金项目(A2015350) (A2015350)

广州市公共卫生服务体系建设研究基地2016年度课题成果 ()

中国感染控制杂志

OA北大核心CSTPCD

1671-9638

访问量0
|
下载量0
段落导航相关论文